Gynesonics Names Industry Veteran Skip Baldino President and CEO, Announces $25M Financing to Expand Worldwide Commercialization
Mr. Baldino, who will also serve as member of the Board of Directors, succeeds Christopher Owens.
- Mr. Baldino, who will also serve as member of the Board of Directors, succeeds Christopher Owens.
- Gynesonics is also pleased to announce that the company has closed on a significant financing of $25M to help further drive the growth and adoption of the Sonata® System.
- Mr. Baldino has over 35 years of healthcare experience in both private start-ups and large public companies.
- “I am excited to join the Gynesonics team at this pivotal point in the company’s commercial evolution,” said Mr. Baldino.